MODELS TO PREDICT HEALTH UTILITIES IN PATIENTS WITH LOW BACK PAIN

Published Sep 29, 2014
Coventry, UK - Low back pain (LBP) is a major public health problem in western industrialised societies. To make the best use of limited resources, planning of health care interventions is important. Models that translate patient outcomes into health utilities are valuable for decision makers planning these interventions. In the study, “Mapping between the Roland Morris Questionnaire and Generic Preference-Based Measures,” published in Value in Health, researchers from the United Kingdom used mapping techniques, accepted statistical methods for defining a relationship between two health outcome measures, to generate EQ-5D and SF-6D health utilities from Roland Morris Questionnaire (RMQ) data.  A wide variety of statistical models were explored in the estimation of the mapping algorithms and validated using external data. A number of models were developed that predict health utilities in this context and the best performing models were a Beta regression model and a finite mixture model. Study co-author Stavros Petrou, PhD, from the University of Warwick says, “This research shows that it is possible to reasonably predict EQ-5D and SF-6D health utilities from RMQ scores and responses using regression methods. These results can be used to inform utility estimation within future economic evaluations and aid decision makers.”

Related Stories

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×